TANC2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.276000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.336600E-01
Normal-vs-Stage2
8.160800E-01
Normal-vs-Stage3
7.299000E-01
Normal-vs-Stage4
9.985400E-01
Stage1-vs-Stage2
9.117200E-01
Stage1-vs-Stage3
8.192200E-01
Stage1-vs-Stage4
7.989600E-01
Stage2-vs-Stage3
6.834000E-01
Stage2-vs-Stage4
7.851400E-01
Stage3-vs-Stage4
6.709000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.951400E-01
Normal-vs-AfricanAmerican
7.542400E-01
Normal-vs-Asian
6.808600E-01
Caucasian-vs-AfricanAmerican
2.988000E-01
Caucasian-vs-Asian
6.826400E-01
AfricanAmerican-vs-Asian
2.743200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.371600E-01
Normal-vs-Female
8.317600E-01
Male-vs-Female
9.581800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.563200E-01
Normal-vs-Age(41-60Yrs)
6.712000E-01
Normal-vs-Age(61-80Yrs)
5.749000E-01
Normal-vs-Age(81-100Yrs)
7.548400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.502200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.329400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.781200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.415800E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.080030E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.554400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.279000E-01
Normal-vs-Daily Drinker
2.980800E-01
Normal-vs-Weekly Drinker
8.533800E-01
Normal-vs-Occasional Drinker
7.387400E-01
Normal-vs-Social Drinker
9.058800E-01
Non Drinker-vs-Daily Drinker
4.370200E-01
Non Drinker-vs-Weekly Drinker
3.787800E-01
Non Drinker-vs-Occasional Drinker
9.701700E-02
Non Drinker-vs-Social Drinker
1.666020E-01
Daily Drinker-vs-Weekly Drinker
1.096020E-01
Daily Drinker-vs-Occasional Drinker
3.810000E-02
Daily Drinker-vs-Social Drinker
9.444200E-02
Weekly Drinker-vs-Occasional Drinker
3.115800E-01
Weekly Drinker-vs-Social Drinker
6.024600E-01
Occasional Drinker-vs-Social Drinker
6.571800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.403600E-01
Normal-vs-Grade 2
2.246600E-01
Normal-vs-Grade 3
2.695200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.046400E-01
Grade 1-vs-Grade 3
6.423700E-02
Grade 1-vs-Grade 4
4.403600E-01
Grade 2-vs-Grade 3
1.185200E-01
Grade 2-vs-Grade 4
2.246600E-01
Grade 3-vs-Grade 4
2.695200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.694600E-01
Normal-vs-NonDiabetic
8.849200E-01
Diabetic-vs-NonDiabetic
1.645570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.120000E-01
Normal-vs-NoPancreatitis
8.158400E-01
Pancreatitis-vs-NoPancreatitis
5.975600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.712800E-01
Normal-vs-N1
8.449600E-01
N0-vs-N1
6.439000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.069200E-01
Normal-vs-TP53-NonMutant
7.753400E-01
TP53-Mutant-vs-TP53-NonMutant
1.837450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
